BR112022009878A2 - Método para determinar uma pontuação de risco para um paciente - Google Patents

Método para determinar uma pontuação de risco para um paciente

Info

Publication number
BR112022009878A2
BR112022009878A2 BR112022009878A BR112022009878A BR112022009878A2 BR 112022009878 A2 BR112022009878 A2 BR 112022009878A2 BR 112022009878 A BR112022009878 A BR 112022009878A BR 112022009878 A BR112022009878 A BR 112022009878A BR 112022009878 A2 BR112022009878 A2 BR 112022009878A2
Authority
BR
Brazil
Prior art keywords
patient
risk score
present
computer
relates
Prior art date
Application number
BR112022009878A
Other languages
English (en)
Inventor
Andrews Brian
Original Assignee
Moelnlycke Health Care Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moelnlycke Health Care Ab filed Critical Moelnlycke Health Care Ab
Publication of BR112022009878A2 publication Critical patent/BR112022009878A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/044—Recurrent networks, e.g. Hopfield networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)

Abstract

MÉTODO PARA DETERMINAR UMA PONTUAÇÃO DE RISCO PARA UM PACIENTE. A presente invenção refere-se, em geral, a um método implementado por computador para atualizar um modelo de tratamento para um paciente. A presente invenção também se refere a um sistema de computador e a um produto do tipo programa de computador correspondente.
BR112022009878A 2019-12-03 2020-12-02 Método para determinar uma pontuação de risco para um paciente BR112022009878A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1951381 2019-12-03
PCT/SE2020/051160 WO2021112748A1 (en) 2019-12-03 2020-12-02 A method for determining a risk score for a patient

Publications (1)

Publication Number Publication Date
BR112022009878A2 true BR112022009878A2 (pt) 2022-08-09

Family

ID=76222618

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022009878A BR112022009878A2 (pt) 2019-12-03 2020-12-02 Método para determinar uma pontuação de risco para um paciente

Country Status (8)

Country Link
US (1) US20220406466A1 (pt)
EP (1) EP4073819A4 (pt)
JP (1) JP2023505435A (pt)
CN (1) CN114762061A (pt)
AU (1) AU2020396435A1 (pt)
BR (1) BR112022009878A2 (pt)
CA (1) CA3160255A1 (pt)
WO (1) WO2021112748A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022328131A1 (en) * 2021-08-09 2024-02-15 Y-Prime, LLC Risk assessment and intervention platform architecture for predicting and reducing negative outcomes in clinical trials
US20230178202A1 (en) * 2021-12-02 2023-06-08 CadenceRx Methods and Systems for Managed Authorization Routing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060167721A1 (en) * 2004-12-30 2006-07-27 Betty Bernard Methods for patient care using acuity templates
US20070228721A1 (en) * 2006-02-15 2007-10-04 Michael Laposata Systems and devices for assessment and treatment of a myocardial ischemic event
WO2009002620A1 (en) * 2007-06-27 2008-12-31 F. Hoffman-La Roche Ag System and method for developing patient specific therapies based on modeling of patient physiology
US20090247834A1 (en) * 2008-03-28 2009-10-01 Schechter Alan M Quality of life management program
US20110071363A1 (en) * 2009-09-22 2011-03-24 Healthways, Inc. System and method for using predictive models to determine levels of healthcare interventions
US8676607B2 (en) * 2011-01-10 2014-03-18 Medimpact Healthcare Systems, Inc. Obtaining patient survey results
WO2016008954A1 (en) * 2014-07-15 2016-01-21 Institut National De La Recherche Agronomique Gut bacterial species in hepatic diseases
US10123748B2 (en) * 2014-10-30 2018-11-13 International Business Machines Corporation Active patient risk prediction
US20160283686A1 (en) * 2015-03-23 2016-09-29 International Business Machines Corporation Identifying And Ranking Individual-Level Risk Factors Using Personalized Predictive Models
US20180075207A1 (en) * 2015-07-24 2018-03-15 Solera Health, Inc. Systems and Methods For Performing Health Risk Assessments and Risk Stratification On A Patient Population
US10431343B2 (en) * 2016-05-23 2019-10-01 Koninklijke Philips N.V. System and method for interpreting patient risk score using the risk scores and medical events from existing and matching patients
US20180165418A1 (en) * 2016-12-08 2018-06-14 Welltok, Inc. Health recommendations based on extensible health vectors
CN107609980A (zh) * 2017-09-07 2018-01-19 平安医疗健康管理股份有限公司 医疗数据处理方法、装置、计算机设备及存储介质
US20190108912A1 (en) * 2017-10-05 2019-04-11 Iquity, Inc. Methods for predicting or detecting disease
US11101039B2 (en) * 2018-03-02 2021-08-24 Jack Albright Machine-learning-based forecasting of the progression of Alzheimer's disease

Also Published As

Publication number Publication date
WO2021112748A1 (en) 2021-06-10
AU2020396435A1 (en) 2022-06-02
CA3160255A1 (en) 2021-06-10
US20220406466A1 (en) 2022-12-22
EP4073819A4 (en) 2024-01-03
JP2023505435A (ja) 2023-02-09
EP4073819A1 (en) 2022-10-19
CN114762061A (zh) 2022-07-15

Similar Documents

Publication Publication Date Title
BR112016006635A2 (pt) método de seleção dentre uma pluralidade de planos de tratamento para tratar um tumor, e, produto de computador
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
NZ730809A (en) Methods for treating filoviridae virus infections
BR112015023349A2 (pt) composto, composição farmacêutica, e, método de tratamento de uma doença, condição de saúde ou distúrbio
AU2014375637A1 (en) Formula of neuregulin preparation
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
BR112019003577A2 (pt) métodos de tratamento da semente e produtos resultantes
BR112016014876A2 (pt) composto que modula a quantidade ou a atividade de gibspla2, composição farmacêutica, imunógeno que induz uma resposta imune anti-gibspla2, composição de vacina, método para o diagnóstico da imunodeficiência humana associada com a alteração de células t, e, método para a produção de gibspla2
BR112022009878A2 (pt) Método para determinar uma pontuação de risco para um paciente
BR112014029346A2 (pt) sistema e método implementado por computador para a montagem de um plano de tratamento médico
MX370270B (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
BR112017012603A2 (pt) desfibrilador externo automático (dea), e método para fornecer orientação a um usuário de um desfibrilador durante a aplicação da reanimação cardiopulmonar (rcp)
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
BR112017016194A2 (pt) método
TW201613639A (en) Methods for treating cardiovascular diseases
BR112015030099A2 (pt) marcador para desordens de esfingomielinase ácida e usos do mesmo
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
BR112017009448A2 (pt) método para tratamento da doença de huntington, método para desaceleração da progressão de atrofias cerebral e estriatal em um indivíduo acometido de doença neurodegenerativa, e método para tratamento de distonia em um indivíduo acometido de uma doença neurodegenerativa
MX2020003243A (es) Métodos para tratar la insuficiencia cardíaca con fracción de eyección preservada.
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
BR112017012911A2 (pt) método para tratamento de insuficiência cardíaca
BR112016029926A2 (pt) administração nasal